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Abstract—Clustering cancer patients into subgroups and iden-
tifying cancer subtypes is an important task in cancer genomics.
Clustering based on comprehensive multi-omic molecular pro-
filing can often achieve better results than those using a single
data type, since each omic data type (representing one view of
patients) may contain complementary information. However, it is
challenging to integrate heterogeneous omic data types directly.
Based on one popular method – Similarity Network Fusion (SNF),
we presented Affinity Network Fusion (ANF) in this paper, an
“upgrade” of SNF with several advantages. Similar to SNF, ANF
treats each omic data type as one view of patients and learns a
fused affinity (transition) matrix for clustering. We applied ANF
to a carefully processed harmonized cancer dataset downloaded
from GDC data portals consisting of 2193 patients, and generated
promising results on clustering patients into correct disease
types. Our experimental results also demonstrated the power
of feature selection and transformation combined with using
ANF in patient clustering. Moreover, eigengap analysis suggests
that the learned affinity matrices of four cancer types using
our proposed framework may have successfully captured patient
group structure and can be used for discovering unknown cancer
subtypes.
I. INTRODUCTION
Cancer genomics projects such as TCGA have generated
comprehensive multi-omic molecular profiling for dozens of
cancer types. Mining huge amounts of omic data to discover
cancer subtypes and disease mechanisms is still a hot topic.
As patients with cancer from the same primary sites, for
example, lung cancer, can be very different from each other
in terms of disease progression, response to treatments, etc.
One important task is to further cluster cancer patients of
the same cancer type into subgroups and define new cancer
subtypes with comprehensive molecular signatures associated
with distinct clinical features.
There are many challenges to cluster patients into subgroups
since cancer patients are very heterogeneous. Even though we
can always cluster patients into groups by running a specific
clustering algorithm, the clustering results may not be robust,
i.e., slightly changing clustering methods or parameter settings
may lead to a different clustering result. Moreover, there is no
groundtruth to decide which methods and parameter settings
work best. While the omic data collected are comprehensive,
they are heterogeneous and noisy, too. If we use each type
of omic data to cluster patients, we can probably generate
different results. Is it possible to generate a robust clustering
result and use “groundtruth” to justify it? This paper mainly
focus on this problem.
Since each type of omic data may contain some com-
plementary information about the patients and disease, we
can perform integrative network analysis with multi-omic
data. Many methods that have been developed to integrate
multi-omic data for patient clustering in the past several
years are either based on probabilistic models or network
models [1]. It has been demonstrated that patient clustering
based on similarity network fusion (SNF) [2] can usually
achieve promising results compared with other methods such
as iCluster [3] or KMeans. While SNF works well in clustering
patients, we find that the required computational operations
in SNF can be significantly reduced and simplified to get a
reliable fused affinity network. Based on SNF, in this paper
we presented Affinity Network Fusion (ANF) with several
advantages compared with SNF.
Our contribution can be summarized as follows:
First, ANF presented here can be seen as an improved
version of SNF with several advantages. ANF requires much
less computation while generating as good as or even better
results than those from SNF. ANF can incorporate weights of
each view, while SNF is unweighted. Moreover, ANF has a
much more clearer interpretation, while SNF contains some
“mysterious” operations.
Second, we cleverly selected a “gold” dataset with true class
labels for cancer patients clustering problem. Thus instead
of using internal clustering evaluation metrics, we were able
to use external metrics to evaluate clustering methods. We
used the newest release of harmonized cancer datasets from
Genomic Data Commons Data Portal (since the data is har-
monized, it is of high quality for large-scale integration), and
carefully selected 2193 cancer patients from four primary sites
with known disease types. With this dataset, we were able to
demonstrate the power of affinity network fusion technique in
cancer patient clustering. Our experimental results also showed
survival information alone may not be sufficient for evaluating
disease (sub)type discovery methods.
Third, using harmonized gene expression and miRNA ex-
pression data, we were able to demonstrate that feature se-
lection and transformation of “raw” counts or other genomic
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features could lead to better clustering results. Specifically, we
find that log transformation or variance stabilizing transforma-
tion [4] of raw counts data usually perform better than directly
using normalized expression values such as FPKM values of
gene expression.
Forth, the experimental results on this relatively large
dataset (2193 cancer patients with gene expression, miRNA
expression and DNA methylation data) are very promising.
The learned fused affinity matrices for the selected four
cancer types matched well with both true class labels and
the theory of spectral clustering based on eigengap analysis
(Sec. V-E), which can be reliably used for unknown cancer
subtype discovery and identifying subtype-specific molecular
signatures.
The rest of paper is organized as follows. In section II,
we briefly summarize some related work. In section III, we
briefly describe a general framework for clustering complex
objects. In section IV, we describe ANF framework in detail.
In section V, we presented experimental results and analysis.
The last section gives conclusion.
II. RELATED WORK
Integrating multi-omic data has been a hot topic in recent
years. There are multiple good reviews on this topic [1], [5].
Various techniques can be classified into four groups based
on whether they are probabilistic or network based: Non-
Probabilistic Non-Network, Non-Network Probabilistic, Non-
Probabilistic Network, and Probabilistic Network.
Non-Probabilistic Non-Network approaches do not assume
a probability distribution or use graph theory to integrate multi-
omic data. Instead direct regression or correlation analysis
are applied to multi-omic data. For example, partial least
square can identify the features that are most informative
for predicting clinical outcomes, and can weigh different
sources. Canonical Correlation Analysis leverages correlations
among different features in various sources to select the most
informative features. Some frameworks apply Expectation-
Maximization approaches to learn the weight of each source
in the optimization framework.
Non-Network Probabilistic approaches refer to methods that
employs a probabilistic approach containing latent variables
with a prior distribution. For instance, iCluster [3], a widely
used cancer subtype clustering method, assumes different
types of data share a common latent feature space that can be
learned through Expectation-Maximization (EM). Clustering
is performed on the learned latent feature space.
Non-probabilistic network approaches often do not assume
a prior distribution of a set of latent variables. In fact, many
models of this category even do not have latent variables. Most
of them try to leverage interaction network to diffuse the signal
and fuse various networks. Typical examples include HotNet2
[6] and SNF [2]. HotNet2 diffuses genetic mutation signals
through gene interaction network to get a smoothed mutation
profile, which is then used for detecting “hot spot” of gene
subnetworks that might be disease-causing. SNF constructs
patient similarity networks using different types of data. The
novelty of SNF is that it fuses different patient similarity
networks to achieve a consensus similarity network that could
be more reliable instead of directly combing heterogeneous
features. The fused patient similarity network is then used for
clustering patients into disease subtypes.
Probabilistic network approaches usually employs Bayesian
approaches, which usually incorporate latent variables and
factors into the model and learn these variables and factors
through optimization frameworks. External sources such as
interaction networks or pathways are often used to construct
the network or factor graph. For instance, PARADIGM [7]
converted NCI pathway databases into a factor graph in
which each gene is a factor incorporating several kinds of
information. Since most of the variables and factors in this
factor graph are unknown, PARADIGM relied on a set of
empirical distributions to make the learning task possible with
EM algorithm.
Our approach presented in this report roughly falls into
the third category – non-probabilistic network approach. We
do not assume a prior distribution for any variables to avoid
unrealistic assumptions. Instead we adopted the techniques in
spectral clustering to construct a k-nearest-neighbor affinity
(similarity) graph with local Gaussian kernel (Eq. 5). This will
reduce noise and possible distortion caused by non-uniform
measurements and preprocessing of omic datasets. Based on
the main idea of similarity network fusion (SNF) [2], we
developed a simpler and more general framework of affinity
network fusion (ANF), or more technically speaking, transition
matrix fusion, to combine multiple networks into a fused
consensus network. The learned affinity network captures
complementary information from multiple views and is much
more robust than individual networks learned from each view.
III. GENERAL FRAMEWORK TO CLUSTER COMPLEX
OBJECTS
A. Representing Complex Objects With Multi-View
A patient is a complex object, and can have multiple views
with heterogeneous features. In this paper, we mainly deal
with patient clustering. However, the proposed framework can
be used for any complex object clustering.
Suppose each patient has n-views. Thus we have n patient-
feature matrices:
X (v) ∈ RN×pv , v = 1, 2, · · · , n
N : number of patients
pv : feature dimension in view v
Here we assume each feature can be mapped to a vector
of real numbers. Note that there are quite a lot of features
that are not numeric, such as text annotations. However, many
of them can be transformed to a new feature space in Rp
using feature embedding. In this paper, we do not focus on
transforming a specific non-numeric feature space to Rp, but
focus on clustering patients based on already transformed
feature matrices in RN×pv .
B. Feature Selection and Transformation
For patients, each type of omic data is different, representing
a different view of the patients. The dimensionality of each
view is usually very high. Feature selection and transformation
are often necessary. For example, gene expression data can
be represented using a sample-feature matrix with tens of
thousands of rows (i.e., genes) and dozens of columns (i.e.,
samples). Most genes are not disease genes. If we use all gene
features for clustering patients into subgroups, irrelevant gene
features may lead to a “bad” clustering result.
For cancer genomics, we usually have expression data
from tumor-normal pairs, which can be used for selecting
differentially expressed (DE) genes (or miRNAs). Using DE
genes for clustering patients is often better than using all genes
[8].
In genomics, raw counts of molecular measurements are
common. However, for clustering or other exploratory anal-
ysis, direct use of raw counts is usually discouraged. Proper
feature normalization and transformation is often necessary
before clustering. Log transformation, variance stabilizing
transformation [4], and regularized log transformation [9]
are commonly used for transforming raw counts data for
downstream analysis.
C. Distance Metrics
Most clustering techniques require to define a pair-wise pa-
tient distance (or similarity) matrix ∆ = (δij)N×N ∈ RN×N+ .
R+ represents the set of non-negative real numbers.
With proper feature engineering, we can calculate pair-
wise distance on normalized features using Euclidean distance
δij = ||xi−xj ||, or δij = 1−Cor(xi, xj) (Cor(xi, xj) repre-
sents Pearson (or Spearman) correlation), etc. For categorical
features without feature embedding, we can use chi-squared
distance or other similar metrics.
D. Clustering Objectives
To find a clustering assignment function A =
(a1, a2, · · · , aN ) that maps each patient i to a unique
cluster ai (here we do not consider soft clustering) with
certain constraints (e.g., the number of clusters), we need
solve an optimization problem in general:
arg min
A
f(A,∆) (1)
f is a cost function that aims to make patients in the
same cluster are more “like” each other than those belong
to different clusters.
Once common choice is to minimize the ratio between
the sum of intra-class distances and the sum of inter-class
distances.
arg min
A
∑
1≤i,j≤N I(ai = aj)δij∑
1≤i,j≤N I(ai 6= aj)δij
(2)
I(·) is the indicator function. Many clustering methods
essentially solve this problem or its variants directly or in-
directly. If the distance between patients is not very accurate
due to noise and feature heterogeneity, etc., we can build a
similarity graph based on distance matrix ∆, then perform
graph cut to find densely connected clusters. A powerful
approach is spectral clustering that work on patient similarity
graph S = (sij)N×N ∈ RN×N+ [10]. In this paper we used
spectral clustering [10] on learned fused affinity (similarity)
matrix for patient clustering.
IV. KNN AFFINITY NETWORK FUSION (ANF)
A. Affinity Matrix for Each View
With pair-wise distance matrix ∆, we can define corre-
sponding similarity graph S in multiple ways. For example
[10],
•  neighborhood: only the edges that has weight less than
 are kept in the similarity graph. The choice of  is
problem-dependent.
• k-nearest-neighbor graph: only the edges of each node’s
k-nearest neighbors are kept. k is the parameter to tune.
• Fully connected graph: a kernel such as e−
δ2ij
2σ2 is often
used to transform distance to similarity. σ is the radius
of a local neighborhood instead of a global constant to
capture local network structure.
In this paper, we adopted the definition of local σij from
[2].
µi =
∑
l∈Nk(i) δil
k
(3)
σij = α(µi + µj) + βδij (4)
Nk(i) represents the indexes of k-nearest neighbors of
patient i. Thus µi in Eq. 3 represents local diameter of node i.
σij in Eq. 4 incorporates both local diameters of patient i and
j and their distance. The choice of k is important and needs
to be tuned. In [2], σij =
µi+µj+δij
3 . Eq. 4 is more general
with tuning parameters α and β, α, β ≥ 0.
Kij =
1√
2piσij
e
− δ
2
ij
2σ2
ij (5)
Eq. 5 calculates local Gaussian kernel between patient i
and j, with σij defined as Eq. 4, to incorporate local kNN
network structure. Even though K is fully connected (i.e.,
∀i,∀j,Kij > 0), only those node pairs that are within a small
dense neighborhood will have a relatively large kernel (as
similarity measure). We can regard K as a similarity graph
to perform spectral clustering.
With similarity matrix K, we can define a state transition
matrix by Eq. 6, with Sij representing the probability of (the
state of) patient i transition to (the state of) patient j. Each
row of S sums to 1.
Sij =
Kij∑N
j=1Kij
, 1 ≤ i, j ≤ N (6)
While K is symmetric, S is probably not. We use transition
matrix instead of symmetric similarity matrix to make the our
framework interpretable through random walk.
kNN Affinity Matrix for Each View With multi-view data,
one can perform clustering on each view and synthesize results
using approaches like consensus clustering [11]. Or we can
construct a more robust similarity network incorporating multi-
view data and then perform spectral clustering.
For each view, we can calculate state transition matrix S(v)
using Eq. 6. Since S(v) is normalized from similarity matrix
(Eq. 5), we can easily recover a symmetric similarity graph
from S(v). Thus we loosely refer S(v) as fully-connected
similarity graph or affinity matrix in this paper.
Based on fully connected graph S(v), we can further define
k-nearest-neighbor similarity graph or affinity matrix as W (v)
(Eq. 7).
W
(v)
ij =

(1− ) S
(v)
ij∑
j∈Nk(i) S
(v)
ij
, if j ∈ Nk(i)

S
(v)
ij∑
j /∈Nk(i) S
(v)
ij
, otherwise
(7)
Nk(i) refers to the indexes of k nearest neighbors of patient
i.  refers to a small number. If we set  = 0, then for each row
of W (v), only k elements are non-zero, and only the weights
of k nearest neighbors are used for normalization. We also
loosely call W (v) a (kNN) affinity matrix in this paper.
Since each row sums to 1, W (v) is also a transition matrix.
In fact W (v) can be seen as a trunked version of S(v) by
“throwing away” weak signals (i.e., small edge weights) in
S(v). Thus W (v) should be more robust to small noise. If
W (v) represents a connected and non-bipartite graph, it will
reach a unique stationary distribution after a sufficient number
of random walk [10].
When we cluster N patients into several groups, we essen-
tially try to find several different “stable” state space. Patients
will be much more likely to stay in their own state space
than to transition to another state space. Thus we can find a
graph cut based on its transition matrix. For a network with
multiple possible transition matrices from multi-view, we can
use random walk on multigraph to aggregate all transition
matrices to get a fused transition matrix for spectral clustering.
This is the main idea of affinity network fusion (ANF) in this
paper.
B. Affinity Network Fusion with One-step Random Walk
(ANF1)
For each view, we have defined two transition matrices :
S(v) (representing fully connected affinity network, Eq. 6),
and W (v) (kNN affinity network, a trunked version of S(v),
Eq. 7). We can build a multi-graph G to incorporate multi-
views. In G, each node represents a patient. There can be at
most n (or 2n if we include two edges from each view using
Eq. 6 and Eq. 7) edges between patients.
To calculate an aggregated edge weight for each patient pair,
we can apply one-step random walk to fuse multi-view affinity
networks in two steps. First, we use Eq. 8 to “smooth” each
view. Then we use Eq. 11 to get a fused weighted view.
W (v) = β1W
(v) + β2W (−v) + β3S(v) + β4S(−v) (8)∑4
v=1 βv = 1, βv ≥ 0
W (−v) =
∑
k 6=v
wk ·W (k) (9)
S(−v) =
∑
k 6=v
wk · S(k) (10)
W =
n∑
v=1
wv ·W (v) (11)
∑n
v=1 wv = 1, wv ≥ 0
In Eq. 8, the second term W (−v) represents a weighted
complementary view from n − 1 other views (Eq. 9). Term
3 and term 4 in Eq. 8 are included for comprehensiveness.
In practice, since W (v) is usually more robust to noise than
S(v), we often set β3 = β4 = 0. Eq. 8 can be interpreted as
network diffusion between view v and other complementary
views, resulting in a smoother version of W (v).
Since all W (v) and S(v) are transition matrices, the fused
view Eq. 11 essentially computes a weighted transition matrix
W , which combines complementary information from multi-
views and could be more informative for patient clustering.
We can interpret the fused view W (Eq. 8 and 11) as the
result of one-step random walk on a multigraph, with W
being an aggregated transition matrix of a simple graph derived
from multigraph. We call this process Affinity Network Fusion
(ANF). Even though it is very simple, it turned out to be as
powerful as SNF [2] (see Sec.V).
To get an aggregated transition matrix, we can have multi-
step random walk. In the following, we refer to ANF with one-
step random walk as ANF1, and ANF with two-step random
walk as ANF2, which is to be discussed in the next session.
C. Affinity Network Fusion with Two-step Random Walk
(ANF2)
In addition to one-step random walk, we can have multi-
step random walk on multigraph. Our experiments on cancer
genomic data showed a one-step or two-step random walk can
usually work well enough. If the number of steps are too big,
the fused transition matrix W can eventually become rank 1,
with each row being the same as the stationary distribution.
Thus we only consider network fusion with two-step random
walk in the following.
Similar to one-step random walk, we derive the fused
transition matrix with two steps: first calculate a smoothed
transition matrix for each view using Eq. 12, then aggregate
all views using Eq. 11.
W (v) =α1W
(v) ·W (−v) + α2W (−v) ·W (v)+
α3W
(v) · S(−v) + α4S(−v) ·W (v)+
α5S
(v) ·W (−v) + α6W (−v) · S(v)+
α7S
(v) · S(−v) + α8S(−v) · S(v)
(12)
∑8
i=1 αi = 1, αi ≥ 0
The first term of Eq. 12, α1W (v) ·W (−v) represents a two-
step random walk (multiplying two transition matrices): the
first step is a random walk on view v, the second step is a
random walk on the aggregated complementary view (W (−v),
Eq. 9). Similarly, the second term represents random walk on
the complementary view first followed by random walk on
view v. Since we have two transition matrices W (v) and S(v),
we can perform random walks on either W (v) or S(v). The
other six terms in Eq. 12 have similar meanings as the first
two.
Our experiments on cancer genomic data show that the
terms using W (v) usually works better than using S(v),
suggesting W (v) is more reliable than S(v). In practice, the
default choice is just using the first two terms:
W (v) = αW (v) ·W (−v) + (1− α)W (−v) ·W (v) (13)
D. Comparison with SNF from [2]
ANF is based on SNF [2], but is much more simpler and
as powerful as SNF. In SNF, the network fusion process is
performed iteratively (Eq. 14):
S(v) = W (v) ×
∑
k 6=v S
(v)
n− 1 ×W
(v)T (14)
Note the notations used in this paper are different from
those in [2]. In [2], S(v) represents a symmetric similarity
matrix derived from Eq. 5, while in our paper S(v) is a
row-normalized asymmetric affinity (transition) matrix. Even
though it is intuitive enough, SNF does not have a clear
physical interpretation by multiplying similarity matrix (S(v))
with transition matrices (W (v)) in Eq. 14. However, if we
consider S(v) as a transition matrix, then Eq. 14 can be loosely
seen as a three-step random walk. By contrast, in Eq. 8 and
Eq. 12, ANF directly operates on transition matrices, with
a natural interpretation of random walk on multi-graph to
generate an aggregated simple graph for spectral clustering.
Our experiments showed that increasing the number of steps
of random walk may not increase clustering performance
dramatically. We have also tried iteratively updating W (v) as
in [2]. Results show that it is not necessary to include more
iterations which often cannot outperform simple one-step or
two-step random walk.
In fact, if we adopt an iterative approach to update W (v),
we have to “manually” adjust W (v) after each iteration. In
order to “force” SNF to converge, [2] used a “mysterious”
operation to “avoid numerical instability” of S(v) by forcing
the diagonal of S(v) to be 0.5 after each iteration (Eq. 15). As
a result, the learned fused similarity matrix S contains large
values (≈ 0.5 based on their implementation) in the diagonal,
while all other values are smaller by usually at least one order.
Though the following spectral clustering does not rely on the
diagonal elements, the physical meaning of the learned S in
SNF is not as clear as in ANF, where the learned W is a
weighted transition matrix.
S
(v)
ij =

1
2 , if i = j
1
2
S
(v)
ij∑
j 6=i S
(v)
ij
else
(15)
Based on extensive experiments, we found this iterative pro-
cess is not necessary. Without iterative process, the “forced”
normalization (Eq. 15) can be eliminated, too.
Comparing ANF and SNF, ANF has at least several advan-
tages:
First, it requires much less computation to achieve as good
as or even better results than SNF (see Sec. V). SNF typically
requires about dozens of iterations to converge, while ANF
only needs no iteration. ANF1 (Eq. 8) does not involve
matrix multiplication, ANF2 (Eq. 13) involves two matrix
multiplications, while SNF (Eq. 14) needs perform two matrix
multiplications for each iteration.
Second, ANF is more general framework that can incorpo-
rate weights of views, while SNF only use uniform weights
(Eq. 14). This is important because properly chosen weights
can make fusion process more effective.
Third, ANF has a natural interpretation of random walk
on multi-graph to generate a fused simple graph. The learned
fused affinity matrix W has a natural meaning of weighted
transition matrix incorporating multi-view data, while the
operation in SNF does not have a direct physical meaning,
though it can also be loosely seen as a three-step random
walk.
To sum up, ANF significantly reduces unnecessary opera-
tions in SNF, and provides a more general and interpretable
framework for integrating multi-view data using patient net-
work fusion.
E. Spectral Clustering on Fused Affinity Matrix
With learned fused affinity matrix W , we can perform
spectral clustering by solving an optimization problem Eq. 16
[12].
arg max
Y
Trace((Y TDY )−
1
2Y TWY (Y TDY )−
1
2 )
Y 1K = 1N , Y ∈ {0, 1}N×K
(16)
D is a diagonal matrix with diagonal elements being the
sum of each row in W . Since W generated by ANF is a
transition matrix, D becomes an identity matrix. Eq. 16 finds
clustering assignment matrix Y that maximizes K-way nor-
malized associations [12], which can be solved approximately
by solving Eq. 17 [12].
arg maxTrace(Y TZR)
D−1WZ = ZΛ
RTR = IK , Y 1K = 1N , Y ∈ {0, 1}N×K
(17)
The columns of Z in Eq. 17 are eigenvectors of D−1W (or
W since D is identical matrix). R is orthogonal matrix. We
solve Eq. 17 by iteratively update R and Y [12]. First fix R,
update Y
Yij = I(j = argmax(ZR)ij) (18)
I(·) is indicator function. Then fix Y , update R
Y TZ = UΛV T (19)
R = V UT (20)
Y TZ = UΛV T is the singular value decomposition of Y TZ.
The overall ANF framework to cluster cancer patients is
summarized in Alg. 1.
Algorithm 1: Affinity Network Fusion for Patient Clus-
tering
Input : •Patient-feature matrices (n views):
X (v), v = 1, 2, · · · , n
•Number of clusters: K
•Weight of each view (optional): w
•Other optional parameters, such as weight of
ANF components α
Output: •Fused patient affinity matrix W
•Patient cluster assignment Y
begin
Feature selection and transformation
X (v) → X(v) ∈ RN×pv , v = 1, 2, · · · , n
Calculate pair-wise distance matrix for each view:
∆(v) ∈ RN×N+ , v = 1, 2, · · · , n
Calculate kNN affinity matrix for each view:
W (v), v = 1, 2, · · · , n (Eq. 8 or Eq. 12)
Calculate fused affinity matrix W (Eq. 11)
Spectral clustering on fused affinity matrix W :
(W,K)→ Y (Sec. IV-E)
Return W,Y
end
V. EXPERIMENTAL RESULTS
A. Dataset and Evaluation Metrics
Harmonized cancer datasets were downloaded from Ge-
nomic Data Commons Data Portal (https://portal.gdc.cancer.
gov/). We selected four primary sites with more than one
disease type: adrenal gland, lung, kidney, and uterus. For
example, cancers from adrenal gland has two disease types:
Pheochromocytoma and Paraganglioma (project name: TCGA-
PCPG) and Adrenocortical Carcinoma (project name: TCGA-
ACC). In this paper, for ease of description, we refer to
“cancer types” as cancers from these four primary sites. We
TABLE I
SAMPLE INFORMATION OF FOUR CANCER TYPES
Cancer type Disease type Total
adrenal gland TCGA-ACC 76 253TCGA-PCPG 177
lung TCGA-LUAD 447 811TCGA-LUSC 364
kidney
TCGA-KICH 65
654TCGA-KIRC 316
TCGA-KIRP 273
Uterus TCGA-UCEC 421 475TCGA-UCS 54
want to cluster tumor samples of the same “cancer types”
into known disease types. The number of samples used for
analysis in each cancer type is summarized in Table I (a few
“outlier” samples detected by exploratory data analysis had
already been removed). All these patient samples has gene
expression, miRNA expression and DNA methylation (from
HumanMethylation450 array) data available for both tumor
and normal samples.
While our ultimate goal is to detect cancer subtypes (the
true subtypes are not known yet), it is a good strategy to
evaluate disease subtype discovery methods using a dataset
with groundtruth. The dataset we selected and processed serves
for this purpose well.
For tumors from each primary site, we already know the
disease types. Since we have ground truth disease types, we
can evaluate clustering results using external metrics such as
normalized mutual information (NMI). In addition, we have
cancer patient survival data. We can perform survival analysis
to test if the patient clusters show statistically different survival
distributions.
The three metrics we used to evaluate clustering results
are: (1) Normalized mutual information: NMI(Ω, C) =
I(Ω,C)
(H(Ω)+H(C))/2 ; (2) Adjusted Rand Index (ARI) [13], and (3)
p-value of log rank test of survival distributions of different
patient clusters [14].
We have chosen seven combinations of data types (legend
of Fig. 1) and six feature types of gene expression and
miRNA expression (legend of Fig. 3). For DNA methylation,
we directly used beta values, so it only has one feature
type. Thus in total there are 37 unique combinations of data
types and feature types. We run both ANF1 and ANF2 on
all 37 combinations, and SNF on 24 combinations (ANF is
implemented to work on a single data type as well, while the
implementation of SNF requires input to include at least two
data types). Due to page limit, detailed results including code
can be accessed at https://github.com/BeautyOfWeb/ANF. In
the following, we only show some results to demonstrate the
power of ANF and feature engineering, and compare ANF
with SNF.
B. The Power of Affinity Network Fusion (ANF)
To demonstrate the power of ANF, we compared the clus-
tering results using single data types with those using ANF to
Fig. 1. Power of ANF combining multiple data types
integrate multiple data types. In Fig. 1, we compared seven
different combinations of data types:
• “gene”: gene expression
• “mirnas”: miRNA expression
• “methylation”: DNA methylation (beta values from Illu-
mina Human Methylation 450 platform)
• “gene+mirnas”: combine “gene” and “mirnas” using ANF
• “gene+methylation”: combine “fpkm” and “methylation”
using ANF
• “mirnas+methylation”: combine “mirnas” and “methyla-
tion” using ANF
• “gene+mirnas+methylation”: combine “gene”, “mirnas”,
and “methylation” using ANF
Fig. 1 shows NMI values (between 0 and 1. The larger
NMI value, the better clustering result) of patient clusters
(here we set the number of clusters to be the number of
disease types) using ANF2 framework on the aforementioned
seven combinations of data types (for gene expression, we
used normalized FPKM values; for miRNA expression, we
used normalized counts in Fig. 1). Fig. 1 shows clustering
using DNA methylation beta values performs better than using
FPKM and normalized miRNA expression values for all four
cancer types, suggesting that DNA methylation data may
contain highly relevant information about disease types (and
potentially disease subtypes).
In general a combination of at least two data types usually
yields better clustering results. There are two exceptions
in Fig. 1. For adrenal gland cancer, clustering using DNA
methylation beta values alone yields the best clustering results
(“gene+methylation” can also generate the same result), and
can outperform the results from using a combination of
data types. Again this suggests DNA methylation beta values
contain most relevant information about disease (sub)types.
Another exception is that the clustering result using “mir-
nas+methylation” combination for uterus cancer is lower than
using “methylation” data alone. This is probably due to that the
quality of fused affinity network from miRNA and methylation
data is not as good as that from methylation data alone. For
uterus cancer, clustering using gene or miRNA expression
data alone did a “terrible” job (NMI ≈ 0). However, by
integrating the two data types, the result improves significantly
(NMI=0.30), which demonstrates the power of ANF.
We also find that it is usually not the case that inte-
grating three data types would generate better results than
Fig. 2. -log(p-value) of log rank test of patient survival distributions
that from integrating two data types. However, integrating
more data types tends to make the results more robust
as “gene+mirna+methylation” consistently performs relatively
well across four cancer types, while two data type combina-
tions may fail in some cases. For instance, for uterus cancer,
integrating miRNA and methylation data does not perform
well, while integrating all three types of data performs much
better even though it does not achieve the best result. Note in
Fig. 1, we used ANF2 and did not tune the weight of views.
Better results may be achieved if we tune the weights.
Very similar results are obtained for using Adjust Rand
Index (ARI) as clustering metric (not shown here). Fig. 2
shows −log10(p-value) of log rank test of patient survival
distributions among detected patient clusters. Since we already
know the true disease labels, we added a pink bar labeled
“TrueClass” in Fig. 2 (the other seven bars are one-to-one
matched with Fig. 1 for comparison). Label “TrueClass” does
not correspond to a data type combination, but refers to
the groundtruth cluster assignment (the bar corresponding to
“TrueClass” shows the negative log p-value of log-rank test
of survival distributions of true disease types).
Fig. 2 shows it is not always the case that the p-value
calculated from using true class labels is the smallest (neg-
ative log p-value the largest). In fact, for lung cancer, the
survival distributions of two known disease types do not shown
statistical difference at all, even though we can separate the
two disease types relatively well using clustering. For kidney
cancer, the smallest p-value (p = 4.7 × 10−13) was achieved
using methylation data alone for clustering, but the corre-
sponding clustering accuracy was relatively low (NMI=0.48,
Fig. 1). Using the true class labels of kidney cancer, we can
only achieve p-value = 1.1 × 10−5. This suggests that log-
rank test of survival distributions should not be used as the
only metric to evaluate patient clustering results. This is also
one major reason we carefully select such a dataset with
groudtruth disease type information for evaluation purpose.
With groudtruth disease type information, external evaluation
metrics such as NMI and Adjusted Rand Index (ARI) can be
used. The largest possible value of NMI and ARI is 1 if all
patients are clustered correctively.
C. The Power of Feature Selection and Transformation
Fig. 3 shows the power of feature selection and transfor-
mation of raw counts data (gene and miRNA expression).
Fig. 3. Power of feature engineering
The topleft, topright, and bottomleft panels show NMI of
clustering results using gene expression, miRNA expression,
and a combination of both using ANF. We choose gene
and miRNA expression data because raw counts data are
available for both data types, and we can apply commonly
used feature selection and transformation techniques to raw
counts. We used differential expression analysis to select gene
or miRNAs features, and used two commonly raw counts
transformation techniques: 1) log transformation: log2(n+n0).
(in our experiments, we set n0 = 1, so that zero counts will
be mapped to 0), and 2) variance stabilization transformation
[4].
In Fig. 3 we compared clustering results using six different
features.
• “raw.all”: Raw counts of all genes or miRNAs
• “normalized”: FPKM values of all genes or normalized
counts for all miRNAs
• “raw.sel”: Raw counts of selected (differentially ex-
pressed) genes or miRNAs (Differential expression anal-
ysis was performed using DESeq2 [9])
• “log.all”: Log transformation of raw counts of all genes
or miRNAs
• “log.sel”: Log transformation of raw counts of selected
(differentially expressed) genes or miRNAs
• “vst.sel”: Variance stabilizing transformation of raw
counts of selected genes or miRNAs
The topleft panel of Fig. 3 shows that for all four cancer
types, “log.sel” and “vst.sel” of gene expression will work
relatively well. The topright panel shows that “vst.sel” of
miRNA expression consistently works relatively well across
all four cancer types. When combining both gene expression
and miRNA expression data using ANF (bottomleft panel),
“log.all”, “log.sel”, and “vst.sel” work consistently well. For
each type of feature, combining two data types using ANF im-
proves clustering accuracy. This also demonstrates the power
of ANF, consistent with the analysis of Fig. 1.
“TrueClass” was only shown in bottomright panel to com-
pare the negative log p-value of log-rank test of survival dis-
tributions when true disease labels are used. Some clustering
results have a smaller p-value than the p-value calculated using
true patient groups even when the clustering results are not
100% correct (Fig. 3 bottomleft and bottomright panels). This
is consistent with the analysis of Fig. 2.
Fig. 4. Comparing the performance of SNF and two frameworks of ANF
D. Performance Comparisons with SNF from [2]
Fig. 4 compares the performances of SNF, ANF1 and ANF2
for clustering four cancer types into their known disease types.
Since SNF has shown superior performance over KMeans,
iCluster, and feature concatenation approaches [2], we do not
repeat comparisons with KMeans, iCluster, etc. in this paper.
We have used three types of data: gene expression, miRNA
expression and DNA methylation. The topleft, topright, bot-
tomleft, and bottomright panels correspond to results from four
different combinations of data types.
Except adrenal gland, for which all three methods can
achieve the same clustering accuracy (NMI=0.93, only two
out of 253 samples were misclassified), at least one of ANF1
and ANF2 can achieve slightly better results than SNF.
Though the improvement is not significant, ANF has several
advantages. ANF has a much more transparent interpretation
and uses much less computation compared with SNF. SNF
needs to converge after typically 20 iterations, while ANF
only needs less than half computation required for computing
one single iteration of SNF. Moreover, ANF provides a more
general framework and can incorporate the weights of multiple
views, while SNF only used uniform weights. Taken these
facts into consideration, ANF is better than SNF and thus can
replace SNF for clustering complex patients with multi-view
data.
There is no significant difference using ANF1 and ANF2,
which correspond to one-step and two-step random walk on
a multigraph to generate a fused simple graph for spectral
clustering, respectively.
Both ANF1 and ANF2 has weight parameters for each view.
We found uniform weights can usually do a good job. If we set
the weight of each view to be the NMI value of the clustering
result using that view alone, we can usually get a slightly
better result. However, the optimal weights may not be very
intuitive as simple NMI values. In our experiments (Fig. 1),
we randomly set weights as ( 16 ,
1
3 ,
1
2 ) for gene expression,
miRNA expression and DNA methylation, and can achieve
slightly better results using NMI values as weights in some
cases. We can improve results by tuning weights of each
view, however, this usually requires using true class label
information. In an unsupervised task (our framework ANF is
designed for unsupervised learning, we just used true class
labels to evaluate its performance), we have to use internal
Fig. 5. Eigenvalues of affinity matrix of four cancer types
evaluation metric such as silhouette or resort to some related
information (such as cancer patient survival data) to evaluate
clustering results.
In addition, since ANF framework applied spectral cluster-
ing to a fused affinity matrix, we can use eigengap heuristic to
determine the number of clusters and indirectly assess cluster
quality.
E. Determine the Number of Clusters Using Eigengap Anal-
ysis
In this section, we carefully examine the learned fused
affinity matrices for the four cancer types. We have run ANF
on 37 combinations of features types and data types, We
choose the affinity matrix W with the highest NMI value for
each cancer type for the following analysis.
The fused affinity matrix W generated by ANF is a transi-
tion matrix, and is asymmetric in most cases if the node degree
distribution is non-uniform. We apply spectral clustering on
this affinity network with normalized graph Laplacian L being:
L = I −D−1W (21)
D is a diagonal matrix with diagonal elements being the
row sums of W . Though L is asymmetric, experiments show
that the results can be as good as or slightly better than a
symmetric version of L (one way to get a symmetric L is first
force W to be symmetric W ← (W +WT )/2, then calculate
L). Let’s define asymmetric ratio of W as:
AsymRatio(W ) = ||W−W
T ||2
||W ||2
WT is the transpose of W , and || · || represents Frobenius
norm. The asymmetric ratios of the fused affinity (transition)
matrices W learned by ANF are 0, 0.10, 0.11, 0.11 for adrenal
gland, lung, kidney and uterus, respectively. The eigenvalues
of the corresponding normalized graph Laplacian L are shown
in Fig. 5.
Surprisingly, for adrenal gland, the learned affinity matrix
W is symmetric (with all eigenvalues being real numbers
shown in topleft panel of Fig. 5). With this W , all 253 samples
except one are clustered correctly according true diseae types
(NMI=0.96). For other cancer types, W is not asymmetric
and there are quite a few complex eigenvalues. However, the
imaginary part of eigenvalues are less than 0.02, and the real
part of eigenvalues are at least more than 30 times larger than
TABLE II
CONFUSION MATRIX OF CLUSTERING ADRENAL GLAND
#Clusters TrueClass Clusters
2
C1 C2
TCGA-ACC 0 76
TCGA-PCPG 176 1
3
C1 C2 C3
TCGA-ACC 0 0 76
TCGA-PCPG 155 21 1
4
C1 C2 C3 C4
TCGA-ACC 0 0 76 0
TCGA-PCPG 83 21 1 72
5
C1 C2 C3 C4 C5
TCGA-ACC 0 0 30 46 0
TCGA-PCPG 83 21 0 1 72
the imaginary part. Let’s use perturbation theory to briefly
explain this observation.
We can treat an asymmetric L as a symmetric matrix plus
a perturbation matrix (representing small disturbances):
L = Lsym +H
Based on perturbation theory, as long as H is relatively
“small” than Lsym, the eigenvalues and corresponding eigen-
vectors of L should be near those of Lsym. The eigenvalues of
Lsym are all real numbers with the smallest eigenvalue being
0 (0 ≤ λ1 ≤ λ2 ≤ · · ·λn), and thus the eigenvalues of L
should be approximately the same as those of Lsym.
One interesting property of our defined W and L is the
summation of eigenvalues of L equals to the summation of
the diagonal of L, which equals to:∑N
i=1 λi = N −
∑N
i=1Wii
We observed all eigenvalues (absolute value for complex
value) are in [0,1]. We expect this to be generally true for any
transition matrix W , and thus for L (without rigorous proof).
Importantly, we found eigengap heuristic is very useful
for deciding the number of clusters. For adrenal gland, the
first two smallest eigenvalues are very near 0, while the third
one is about 0.2. The eigengap between the third and second
smallest values is relatively large. This suggests there should
be two “natural” clusters (corresponding to the two nearly 0
eigenvalues). Furthermore, the eigengap between the fourth
and third values is relatively high, too. This suggests we
can use the learned affinity matrix W for disease subtype
discovery for adrenal gland. In fact, when we set the number
of cluster to be 3, our framework will separate 176 “TCGA-
PCPG” samples into two groups consisting 155 samples and
21 samples respectively. If we set the number of clusters to 4,
the 155 samples will be further split into two small groups as
shown in Table. II.
Similarly, for lung cancer, the two smallest eigenvalues are
near zero, and the eigengap between the third and second
values is relatively high. This information alone suggests there
should be two “natural” clusters, which coincide with the two
different disease types.
TABLE III
CLUSTERING ACCURACY OF FOUR CANCER TYPES
Adrenal gland Lung Kidney Uterus
NMI 0.96 0.75 0.84 0.61
ARI 0.98 0.83 0.91 0.78
−log10(p) 6.8 0.04 4.76 12.3
For kidney cancer, three eigenvalues are near 0 while the
eigengap between the fourth and the third one is relatively
big. From this information, we can infer that there should
be three “natural” clusters, which coincide with the fact that
there are indeed three different disease types in kidney cancer.
Our clustering results can achieve high accuracies for adrenal
gland, lung, and kidney cancers (Table III).
For uterus cancer, only one eigenvalue is 0. The eigengap
between the second and first value is already relatively large.
Thus there might not be “natural” clusters (“natural” clusters
emerge from some nearly block diagonal affinity matrix W ).
Consequently, our clustering result only achieves a moderate
accuracy with NMI = 0.61 and adjusted rand index = 0.78.
However, the p-value of log-rank test of survival distributions
of two clusters is 5.4 × 10−13, while the p-value calculated
from the true disease types is 1.38 × 10−12. This suggests
the identified clusters may still be useful to define clinically
different patient groups.
Without true class label information, eigengap analysis can
be used to predict the number of clusters and assess the
“cluster quality” of affinity matrix for spectral clustering.
In fact, the above eigengap analysis of the learned affinity
matrices successfully reveal the potential number of “natural”
clusters and is consistent with spectral clustering theory. This
suggests the four learned fused affinity matrices may have
successfully captured patient group structure, and can be used
for unknown cancer subtype detection (For example, we can
further cluster adrenal gland into more than two clusters as
shown in Table. II).
VI. CONCLUSION
Defining cancer subtypes and identifying subtype-specific
molecular signatures associated with clinical variables is one
major goal for cancer genomics. In this paper, we presented
affinity network fusion (ANF) framework, an upgrade of SNF
[2], for clustering cancer patients by integrating multi-omic
data. ANF has a clear interpretation, is more general than
SNF, and can achieve as good as or even better results than
SNF with much less computation. We performed extensive
experiments on a selected cohort of 2193 cancer patients from
four primary sites and nine disease types, and achieved high
clustering accuracy. With this carefully selected “gold” dataset,
we demonstrated the power of ANF and the power of feature
selection and transformation in cancer patient clustering.
Eigengap analysis on learned fused affinity matrices is
highly consistent with true class label information, which
strongly suggests that the learned affinity matrices may capture
the internal structure of patient groups. We can use these ma-
trices for subsequent cancer subtype discovery. Once disease
subgroups are defined, future work may focus on a relatively
homogeneous group of patients to identify subtype-specific
comprehensive molecular signatures.
While we only reported experimental results on four cancer
types with known disease types, ANF can be used for dis-
covering subtypes of other cancers, and more generally, for
complex object clustering with multi-view feature matrices.
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